The first stop for professional medicines advice

Supply

39 results

Applied filters

Prescribing and ordering available pancreatic enzyme replacement therapies

17 July 2024The availability of pancreatic enzyme replacement therapies (PERTs) varies currently. Use our resources and mini-tool to find matches for licensed products.

Administration of contrast agents under a PGD by multiple HCPs

15 July 2024Whether a healthcare professional (HCP) can prepare and/or administer contrast supplied by another HCP under a PGD will depend on a range of factors.

Using and prescribing thiamine in alcohol dependence

6 June 2024Intramuscular and intravenous thiamine can be used to prevent complications of alcohol dependence such as Wernicke’s encephalopathy.

Prescribing and using thiamine to prevent refeeding syndrome

2 May 2024Intravenous thiamine for prevention of refeeding syndrome should be reserved for those with intestinal failure where the oral or enteral route is unavailable.

Supply and administration of medicines by staff group (P to Z)

2 April 2024Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.

Supply and administration of medicines by staff group (H to O)

2 April 2024Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.

Supply and administration of medicines by staff group (A to G)

2 April 2024Different staff groups have different permissions with respect to medicines supply and administration and it is important to ensure legislation is followed.

Supporting system response to the ADHD medicine shortage

16 November 2023Practical advice for the system in response to the NatPSA for Attention Deficit Hyperactivity Disorder (ADHD) medicines.

Continuing management of the ADHD medicines shortage

16 November 2023Support for the system in continuing to manage supply disruption of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD).

Considerations when prescribing modified-release methylphenidate

16 November 2023Modified-release methylphenidate capsules and tablets differ. Ensure patients receive appropriate treatment, particularly during periods of supply disruption.